A Pilot Study to Assess Impact of Low Dose Melphalan on Disease Burden Measured by Next Generation Sequencing Before Autologous Hematopoietic Cell Transplant (AHCT) for Multiple Myeloma Patients
Latest Information Update: 05 Apr 2024
At a glance
- Drugs Diphenhydramine (Primary) ; Melphalan (Primary) ; Paracetamol (Primary) ; Prochlorperazine (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 01 Apr 2024 Planned End Date changed from 1 Sep 2023 to 1 Mar 2024.
- 01 Apr 2024 Planned primary completion date changed from 1 Jun 2023 to 1 Dec 2023.
- 01 Apr 2024 Status has been changed to withdrawn prior to enrolment.